Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Immune Globulin IV Therapy: Optimizing Care of Patients in the Oncology Setting

Brenda K. Shelton
Julia M. Griffin
Frederick D. Goldman
ONF 2006, 33(5), 911-921 DOI: 10.1188/06.ONF.911-921

Purpose/Objectives: To review major clinical applications of immune globulin IV (IGIV) therapy, properties of currently available IGIV preparations, procedures for dosing and administration, management of infusion-related adverse effects, and strategies for effective patient education.

Data Sources: Published articles, abstracts, and textbook chapters.

Data Synthesis: IGIV therapy supports immune function by providing immunoglobulin G antibodies for protection against pathogens and modulation of autoimmune and other potentially damaging host responses. Licensed uses include treatment of primary immune deficiencies and autoimmune conditions and prophylaxis against viral infection.

Conclusions: The safety and effectiveness of IGIV therapy depend on selection of an appropriate product, dosage, and infusion rate; patient comorbidities and other risk factors; and patient education and treatment adherence.

Implications for Nursing: Nurses have an essential role in the safe and effective use of IGIV, from educating patients about the rationale for and effects of therapy to administering the product and monitoring for adverse effects.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or